Oneliner_657

OneLiner

Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that enhances glucose-dependent insulin secretion and decreases glucagon release. Adverse effects associated with liraglutide include nausea, vomiting, and pancreatitis.